Skip to main content

Table 1 Clinicopathologic characteristics of CRC patients. One thousand four hundred and twenty CRC patients from February 2007 to February 2013 who met the inclusion criteria were analyzed in this study. The clinicopathologic characteristics of 1420 CRC patients and the 409 stage II patients are listed in Table 1. Of the 409 stage II patients, 145 patients (35.5%) were LVI+ and 264 (64.5%) were LVI−

From: Prognostic value of lymphovascular invasion in stage II colorectal cancer patients with an inadequate examination of lymph nodes

Parameters

Overall patients

Stage II patients

 

n (%)

n (%)

Sex

 Female

598 (42.1)

169 (41.3)

 Male

822 (57.9)

240 (58.7)

Age (years)

 ≤65

669 (47.1)

198 (48.4)

 >65

751 (52.9)

211 (51.6)

Tumor site

 Colon

846 (59.6)

217 (53.1)

 Rectum

574 (40.4)

192 (46.9)

Tumor size (cm)

  

 ≤4

688 (48.5)

209 (51.1)

 >4

732 (51.5)

200 (48.9)

Lymphovascular invasion

 Positive

486 (34.2)

145 (35.5)

 Negative

934 (65.8)

264 (64.5)

T-stage

  

 T1

233 (16.4)

 

 T2

393 (27.7)

 

 T3

457 (32.2)

218 (53.3)

 T4

337 (23.7)

191 (46.7)

N-stage

 N0

582 (41.0)

409 (100.0)

 N1

498 (35.1)

 

 N2

340 (23.9)

 

Differentiation degree

 Well

666 (46.9)

198 (48.4)

 Moderate

582 (41.0)

182 (44.5)

 Poor

172 (12.1)

29 (7.1)

CEA

 ≤5ng/ml

836 (58.9)

243 (59.4)

 >5ng/ml

584 (41.1)

166 (40.6)

CA19-9

 ≤37U/ml

1106 (77.9)

322 (78.7)

 >37U/ml

314 (22.1)

87 (21.3)

Retrieved LN

  

 <12

564 (39.7)

164 (40.1)

 ≥12

856 (60.3)

245 (59.9)

Treatment

 ACT

960 (67.6)

265 (64.8)

 SA

460 (32.4)

144 (35.2)

TNM stage

 I

173 (12.2)

 

 II

409 (28.8)

 

  IIA

174 (12.3)

 

  IIB

121 (8.5)

 

  IIC

114 (8.0)

 

 III

838 (59.0)

 

  IIIA

324 (22.8)

 

  IIIB

287 (20.2)

 

  IIIC

227 (16.0)

 

KRAS status

 Wild type

975 (68.7)

248 (60.6)

 Mutant type

445 (31.3)

161 (39.4)

PNI

  

 Positive

276 (19.4)

90 (22.0)

 Negative

1144 (80.6)

319 (78.0)

TB

 Low

995 (70.1)

294 (71.9)

 High

425 (29.9)

115 (28.1)

  1. CRC Colorectal cancer; LN Lymph nodes; PNI Perineural invasion; TB Tumor budding